These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11095375

  • 1. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
    Bhidayasiri R, Katz JA, Sokos DR.
    Am J Gastroenterol; 2000 Nov; 95(11):3321-2. PubMed ID: 11095375
    [No Abstract] [Full Text] [Related]

  • 2. [Angioedema in Crohn's disease possibly due to mesalazine].
    Nguyen-Khac E, Le Baron F, Thevenot T, Tiry-Lescut C, Tiry F.
    Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
    [No Abstract] [Full Text] [Related]

  • 3. Mesalazine-induced aplastic anemia.
    Wiesen A, Wiesen J, Limaye S, Kaushik N.
    Am J Gastroenterol; 2009 Apr; 104(4):1063. PubMed ID: 19259075
    [No Abstract] [Full Text] [Related]

  • 4. Mesalazine-induced lupus.
    Timsit MA, Anglicheau D, Lioté F, Marteau P, Dryll A.
    Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
    [Abstract] [Full Text] [Related]

  • 5. Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.
    Di Cesare A, Fidanza R, Riitano A, Fargnoli MC, Peris K.
    Eur J Dermatol; 2011 Oct; 21(5):784-5. PubMed ID: 21697068
    [No Abstract] [Full Text] [Related]

  • 6. Asacol®-induced neutropenia resolution without the use of granulocyte colony-stimulating factor.
    Fowler BT, Gupta T, Bilal M.
    South Med J; 2010 Nov; 103(11):1167-9. PubMed ID: 20859250
    [Abstract] [Full Text] [Related]

  • 7. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 8. Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis.
    Frattini F, Crestani S, Vescovi PP, Franchini M.
    Hematology; 2013 May; 18(3):181-2. PubMed ID: 23321335
    [Abstract] [Full Text] [Related]

  • 9. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS, Sen R, Dixit G.
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [Abstract] [Full Text] [Related]

  • 10. Mea culpa.
    Hanauer SB.
    Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):409. PubMed ID: 18670441
    [No Abstract] [Full Text] [Related]

  • 11. [Mesalazine is effective in Crohn disease].
    Quartarolo JP.
    Ugeskr Laeger; 2005 Apr 18; 167(16):1767. PubMed ID: 15898611
    [No Abstract] [Full Text] [Related]

  • 12. Myocarditis by mesalazine with cardiac magnetic resonance imaging.
    García-Ferrer L, Estornell J, Palanca V.
    Eur Heart J; 2009 Apr 18; 30(8):1015. PubMed ID: 19168869
    [No Abstract] [Full Text] [Related]

  • 13. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 Apr 18; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
    Hung MJ, Wang CH, Cherng WJ.
    Int J Clin Pract; 2002 Apr 18; 56(1):70-1. PubMed ID: 11831843
    [Abstract] [Full Text] [Related]

  • 15. [Mesalazine is effective in Crohn disease 2].
    Quartarolo JP, Laegemidler F, Eskerod O.
    Ugeskr Laeger; 2005 Mar 14; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Mesalazine-induced acute pericarditis].
    Sierra Ausín M, Rascarachi G, Díez Rodríguez R, Arias Rodríguez L, Del Pozo Maroto E, Muñoz Núñez F.
    Gastroenterol Hepatol; 2010 Apr 14; 33(4):338-9. PubMed ID: 20005014
    [No Abstract] [Full Text] [Related]

  • 18. [Mesalazine is without clinical effect in patients with Crohn disease].
    Munck LK.
    Ugeskr Laeger; 2005 Jan 17; 167(3):302-3. PubMed ID: 15704804
    [No Abstract] [Full Text] [Related]

  • 19. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M, Ikäheimo R, Pietiläinen T.
    Duodecim; 2003 Jan 17; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract] [Full Text] [Related]

  • 20. Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia.
    Kikkawa M, Matsubara S, Takatoku M, Kuwata T, Ohkuchi A, Izumi A, Watanabe T, Suzuki M.
    J Obstet Gynaecol Res; 2008 Apr 17; 34(2):286-90. PubMed ID: 18412800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.